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The avian sarcoma and leukosis virus (ASLV) envelope glycoprotein (Env) is activated to trigger fusion by a two-step
mechanism involving receptor-priming and low pH fusion activation. In order to identify regions of ASLV Env that can regulate
this process, a genetic selection method was used to identify subgroup B (ASLV-B) virus-infected cells resistant to low pH-
triggered fusion when incubated with cells expressing the cognate TVB receptor. The subgroup B viral Env (envB) genes were
then isolated from these cells and characterized by DNA sequencing. This led to identification of two frequent EnvB alterations
which allowed TVB receptor-binding but altered the pH-threshold of membrane fusion activation: a 13 amino acid deletion in
the host range 1 (hr1) region of the surface (SU) EnvB subunit, and the A32V amino acid change within the fusion peptide of
the transmembrane (TM) EnvB subunit. These data indicate that these two regions of EnvB can influence the pH threshold of
fusion activation.
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INTRODUCTION
Avian Sarcoma and Leukosis Virus (ASLV)-receptor interactions
are a useful model system for studying the mechanism of retroviral
entry into cells since there are multiple virus subgroups (designated
A–J) that use different cellular receptors [1]: TVA for ASLV-A [2],
TVB for ASLV-B, ASLV-D, and ASLV-E [3–5], TVC for
ASLV-C [6], and the chicken Na
+/H
+ exchanger type 1 for
ASLV-J [7].
ASLV entry is mediated by the metastable viral envelope
glycoprotein (Env), comprising a surface subunit (SU), which binds
receptor, and a transmembrane subunit (TM). Receptor-interact-
ing determinants have been previously mapped to three variable
regions (designated as hr1, hr2, and vr3) of ASLV SU [8–16]. The
TM protein anchors Env in the viral membrane and contains an
internal fusion peptide located inside its amino terminus [17–20].
TM also contains two heptad regions, designated as HR1 and
HR2, which come together forming a six-helix bundle or hairpin
during membrane fusion [21,22]. The current model of ASLV
entry invokes structural changes in SU which are induced upon
receptor-binding (receptor-priming) leading to TM adopting a pre-
hairpin conformation with its fusion peptide inserted in the target
membrane [17,23–25]. Evidence either for or against lipid-mixing
at this stage has been presented [22,26–28]. Low pH is required to
drive six-helix bundle formation leading to the completion of
membrane fusion [22,24,27–29].
In an effort to explore the ASLV Env fusion mechanism in more
detail we set out to identify determinants of Env, which influence
low pH-dependent fusion. By using a genetic approach that
employed a cell-cell fusion assay we have identified mutations in
the hr1 subregion of SU, and within the fusion peptide of TM,
which render Env less sensitive to fusion activation at low pH,
implicating these two regions in regulating ASLV Env-driven
membrane fusion.
METHODS
Cell lines and Viruses
Chicken DF-1 cells and 293:TVB
S3DDD cells were described
previously [5,30]. The subgroup B ASLV vector, RCASH-B,
encoding hygromycin B phosphotransferase was described pre-
viously [31]. DF-1 cells were transfected with the RCASH-B
vector using the calcium phosphate method and cells chronically
infected with the virus were selected in medium containing
300 mg/ml hygromycin B.
Genetic Selection and Flow Cytometry
Approximately 1610
6 DF-1 cells that were chronically infected
with RCASH-B, and selected in medium containing 300 mg/ml
hygromycin B, were plated with 9610
6 293:TVB
S3DDD cells. The
cells were incubated together for 4 hours at 37
oC, treated with
20 mM MES buffer (pH 5.6) at 37uC to induce cell-cell fusion for
90 mins and then placed under selection in medium containing
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giving rise to the R6 (pH 5.6) cell population. Flow cytometry to
determine EnvB surface expression was performed with a TVB-
immunoadhesin (TVB
S3-IgG) and with a FITC-conjugated
secondary antibody (Dako, Denmark) as described previously [5].
Quantification of R6 (pH 5.6) cell resistance to
syncytia formation
R6 (pH 5.6) cells were plated with 293:TVB
S3DDD cells at ratios
varying from 1:10 to 1:10
6 with the total cell number in each
population held constant at 2610
6 cells per well. After 4 hours at
37uC, the cells were treated with medium buffered with 20 mM
MES pH 5.6 for 90 min at 37uC and then incubated in medium
containing 300 mg/ml hygromycin B for 14 days. Hygromycin
B-resistant colonies were stained with 1% methylene blue/20%
2-propanol/5% acetic acid. Wells containing distinct colonies
were counted and the numbers obtained were corrected using the
following formula: N6(2610
6/R) where N=number of colonies,
and R=number of R6 (pH 5.6) cells plated).
PCR amplification and DNA sequencing
Single cell clones that were resistant to syncytia formation were
isolated from the R6 (pH 5.6) population. The envB genes
contained in these cells were isolated by PCR amplification from
cellular genomic DNA [59-acggtaccgatcaagcatggcatttctgactgga-
taccctgg-39 (sense primer, KpnI site underlined) and 59-acactagt-
gatgccacagtggtacgcgagg-39 (antisense primer, SpeI site under-
lined)] and were subcloned into KpnI/SpeI digested pCI plasmid
(Invitrogen, LaJolla, CA). The DNA sequences of the envB genes
were determined using Big Dye sequencing (Applied Biosystems,
Foster City, CA). PCR amplification was also used to screen
individual single cell clones for the D152–164 mutation using
primers (59-cagaactacaactgctagg-39) and (59-cggtttcgaggagttagagg-
39) which generates either a 209 bp (wild-type) or a 170 bp (D152–
164 mutant) product.
Wild-type and mutant EnvB protein function
Wild-type and mutant envB genes were inserted upstream of the
internal ribosome entry site (ires)- enhanced green fluorescent
protein (eGFP) cassette in the murine leukemia virus-based
retroviral vector pCMMP.IRES.eGFP [32]The MLV vectors
encoding the different envB proteins were produced in the
extracellular supernatants of transiently transfected 293 cells as
described previously [33] and used to infect DF-1 cells. The eGFP
positive cells were sorted 48 hours later on a FACSDiva
(University of Wisconsin Comprehensive Cancer Center, Madi-
son, WI). Cell surface expression and receptor-binding of each
altered EnvB protein was confirmed by flow cytometric analysis as
before. These cells expressing altered EnvB proteins were mixed at
a 1:10 ratio with 293 TVB
S3DDD cells that had been labeled with
40 ng/ml rhodamine 18 (R18) for 30 minutes (Invitrogen, LaJolla,
CA). After 4 hours, medium buffered with MES at pH 5.6, 5.0, or
4.6, was added for 10 minutes at 37uC and cell-cell fusion was
monitored by fluorescence microscopy using an Axiovert25
fluorescent microscope 4–6 hours later.
RESULTS
In order to identify determinants of ASLV Env that influence
receptor-priming and low pH fusion activation, a genetic approach
was used. The principle of this approach, which relied on the
error-prone nature of reverse transcription (error rate between
10
24 and 10
25) [34] to generate mutations during virus replication
and is outlined in Fig. 1A. Briefly, we hypothesized that within
a starting population of cells that are chronically infected with
a replication-competent subgroup B ASLV vector (encoding
hygromycin B phosphotransferase) [31], there would be a sub-
population of cells containing viral variants harboring mutations
which render Env unable to support low pH-dependent mem-
brane fusion. If so, we reasoned that it should be possible to
selectively amplify this class of cells by incubating the whole virus-
infected cell population with an excess of uninfected cells that
express the cognate TVB receptor, inducing cell-cell fusion at low
pH, and then incubating the cells with medium containing
hygromycin B. Under these conditions virus-infected cells resistant
to cell-cell fusion would be selectively amplified: cells that
underwent fusion would give rise to a non-viable syncytium and
excess TVB-expressing cells that had not undergone fusion would
be eliminated from the culture by the hygromycin B selection.
To test this idea, chicken DF-1 cells that were chronically
infected with the subgroup B ASLV vector, RCASH-B, encoding
hygromycin B phosphotransferase [31] were incubated briefly at
pH 5.6 with a 9-fold excess of 293:TVB
S3DDD cells that express
a cytoplasmic tail-truncated form of the TVB receptor [3]. The
mixed cell population was then placed under selection in medium
containing 300 mg/ml hygromycin B. This procedure was re-
peated six times giving rise to a population of infected DF-1 cells
that were highly resistant to low pH-induced syncytia formation
(R6 (pH 5.6) cell population). Flow cytometric analysis performed
with a TVB-immunoadhesin (TVB
S3-IgG) [35] and with a FITC-
conjugated secondary antibody confirmed that cells of the R6
(pH 5.6) cells expressed, on their surfaces, forms of EnvB that were
competent for binding to the TVB receptor (Fig. 1B).
To determine their level of resistance to low pH-induced fusion,
R6 (pH 5.6) cells were incubated briefly at pH 5.6 with different
ratios of 293:TVB
S3DDD cells before selecting in medium
containing 300 mg/ml hygromycin B. The resultant hygromycin
B-resistant colonies serve as a measure of the number of non-fused
virus-infected cells. Based upon this analysis the R6 (pH 5.6) cells
were estimated to be approximately 1000-fold more resistant to
low pH induced cell-cell fusion when compared to the starting
population of virus-infected cells (Fig. 1C).
To identify mutations in the envB gene that are responsible for
the altered fusion phenotype, single cell clones that were resistant
to syncytia formation were isolated from the R6(pH 5.6) popula-
tion. The full-length envB genes in these cells were isolated by PCR
amplification and their DNA sequences were determined. A total
of 22 distinct mutations were identified, most of which were
represented once amongst the clones that were analyzed (data not
shown). However, three mutations were found in multiple clones
and were chosen for further study. One mutation was a single
nucleotide change (A to T) at position 1312 in the envB gene that
led to the loss of a PvuII site and replacement of alanine 32 in the
TM subunit with a valine (A32V) (Fig. 2A). The second mutation
was a deletion of nucleotides 632 to 671 of envB resulting in a 13
amino acid deletion (residues 152–164) within the hr1 region of
SU (Fig. 2A) (D152–164). The third mutant envB gene contained
both the A32V and D152–164 mutations (Fig. 2A). These mutants
were chosen for additional analysis because they were found in
more than one independently-isolated Env DNA fragment and
thus they could not have resulted from an error during PCR
amplification.
To assess the frequency of these mutations in the selected cell
population, envB genes were isolated by PCR amplification from
the bulk R6 (pH 5.6) cell population and subcloned into the pCI
vector, and individual bacterial transformants were screened for
the A32V mutation by PvuII digestion: plasmid DNA containing
ASLV Membrane Fusion
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A32V envB gene is resistant to digestion (uncut/supercoiled)
(Fig. 2B). Transformants were also screened for the D152–164
mutation by a PCR amplification method that generated either
a 209 bp (wild-type) or a 170 bp (D152–164 mutant) product
(Fig. 2C). The A32V and D152–164 mutations were estimated to
be present in the R6 (pH 5.6) cell population at frequencies of
18.6%, and 11.2%, respectively (Fig. 2A) while 3.3% contained
both mutations (Fig. 2A).
To test the function of the altered Env proteins, mutant envB
genes were inserted upstream of the internal ribosome entry site
(ires)- enhanced green fluorescent protein (eGFP) cassette in the
murine leukemia virus-based retroviral vector pCMMP.IRES.eGFP
[32]. These constructs were then used to transduce DF-1 cells that
were then sorted for GFP expression by FACS. Cell surface
expression and the receptor-binding ability of each altered EnvB
protein was then confirmed by flow cytometric analysis using
TVB
S3-IgG and a FITC-conjugated secondary antibody. (Fig. 3A)
ThesecellswerethenincubatedunderdifferentlowpHconditions
at a 1:10 ratio with rhodamine-labeled 293 TVB
S3DDD cells. Cell-
cell fusion was then monitored by fluorescence microscopy. This
analysis revealed that the altered EnvB proteins are resistant to
fusion activation at pH 5.6 as expected (Fig. 3B). However, each
EnvB protein was competent to elicit cell-cell fusion when the cells
were incubated at pH 5.0 or below (Fig. 3B). These studies confirm
that these EnvB mutations alter the pH threshold of EnvB fusion
Figure 1. Selection of ASLV-B infected DF-1 cells that do not undergo low pH-mediated cell-cell fusion. (A) Selection scheme used to identify
subgroup B ASLV-infected cells that are resistant to low pH-mediated syncytia formation. (B) The numbers of hygromycin B-resistant virus-infected
colonies that resulted from cell-cell fusion experiments preformed with 293:TVB
S3DDD cells and either starting population of RCASH-B infected cells
or R6 (pH 5.6) cells, are shown. This experiment was performed in triplicate and the average mean values obtained are shown along with the
standard deviation of the data. (C) Flow cytometric analysis of EnvB expression. Uninfected cells (green histogram), the starting population of RCASH-
B infected DF-1 cells (red histogram, upper panel) and the R6 (pH 5.6) cells (blue histogram, lower panel) were incubated with TVB
S3-rIgG and a FITC-
conjugated anti-rabbit antibody and analyzed by flow cytometry as described previously [5,27].
doi:10.1371/journal.pone.0000171.g001
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conditions.
DISCUSSION
In this report we took advantage a genetic screen that used cell-cell
fusion as the basis for selection to identify mutations intwo regions of
ASLV-B Env that have a significant impact on the pH threshold of
membrane fusion activation. The first of these is the deletion of a 13
amino acid segment (residues 152–164) from the hr1 region of SU.
The second is the A32V amino acid substitution within the internal
fusion peptide region of TM. Either of these mutations, or both in
combination, changes the pH threshold of ASLV Env so that fusion
is driven only under more acidic conditions than are required for the
wild-type viral glycoprotein. Since type I viral glycoproteins are
converted from a metastable native state to a much more stable state
after fusion activation [36], we postulate that the increased acid
requirement exhibited by the mutant EnvB proteins may be due to
their increased stability relative to the wild-type glycoprotein.
Previously, the hr1 region of ASLV SU has been shown to
harbor determinants that dictate receptor binding and usage [8–
10,12–14,16]. In this study we have identified a 13 amino acid
deletion within this region of EnvB, which still permits TVB
receptor-binding but renders Env more resistant to fusion
activation at low pH. This apparent change in Env stability might
indicate hr1 determinant involvement in fusogenic activation of
the viral glycoprotein. Indeed, based upon the expanded host cell-
tropism associated with an hr1 mutation, L154S, it has been
similarly proposed that this region of EnvB might be involved in
fusogenic activation [37]. Altered Env stability might also account
for the TVA-independent infection seen with viruses bearing a six
amino acid deletion within the hr1 region of ASLV-A SU [12].
The finding that the A32V amino acid change in the fusion
peptide of the EnvB TM protein alters the pH threshold of fusion
activation is similar to that made with influenza A virus
hemagglutinin HA2 subunit [38,39]. Since the A32 residue is
conserved in the Env proteins of other ASLV subgroups [18], it
Figure 2. Common envB mutations in the R6 (pH 5.6) cell population. (A) Schematic of the EnvB protein showing host range regions hr1and hr2 of
SU and the fusion peptide (FP) and membrane spanning domain (MSD) of TM. The amino acid sequences of wild-type (WT) Env B and of three
common mutations found in the R6 (pH 5.6) cell population are shown below. The frequencies of each mutation in the R6 (pH 5.6) population are
indicated in parentheses, measured as described in the text (n=number of cloned copies of the envB genes that were characterized). (B)
Representative screen for the A32V mutation. Individual plasmid DNAs containing envB genes were screened for the A32V mutation by digestion
with PvuII as described in the text. Plasmids containing wild-type envB gave rise to a linear 6 kb DNA fragment (lanes 1, 3, 5, and 6) whereas those
containing A32V envB remain undigested (lanes 2 and 4). Lanes 1 and 2: wild-type and A32V envB controls. Lanes 4–6: Individual envB genes cloned
from the R6 (pH 5.6) population. (C) Representative PCR-amplification based screen for the D152–164 mutation as described in the text. Plasmid DNA
containing wild-type envB give rise to a 209 bp DNA fragment (lanes 1 and 4–8), while those containing the D152–164 mutant give rise to a 170 bp
DNA fragment (lanes 2 and 3). Lane 1; wild-type envB control, Lanes 2–7: Individual envB genes cloned from the R6 (pH 5.6) population.
doi:10.1371/journal.pone.0000171.g002
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found that cells expressing A32V subgroup A ASLV Env are
incapable of mediating cell-cell fusion with TVA-expressing cells
at low pH even though the Env protein is expressed on the cell
surface and is capable of binding to soluble TVA receptor (data
not shown). Future studies will be aimed at determining how the
hr1 and fusion peptide regions contribute to the pH threshold of
ASLV Env activation.
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Figure 3. The mutant EnvB proteins exhibit altered low pH thresholds for fusion activation. (A) DF-1 cells (blue histogram) and DF-1 cells
expressing wild-type (WT), and either of the mutant forms of EnvB (red histograms) were analyzed by flow cytometry as described in the Fig. 1
legend. (B)The virus-infected DF-1 cells (GFP-positive green) were mixed with 293:TVB
S3DDD cells labeled by expression of eGFP. The 293:TVB
S3DDD
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